Ani Pharmaceuticals announced the launch of Vancomycin HCl Capsules, the generic version of its Vancocin Capsules.

Vancocin is indicated for the treatment of C. difficile-associated diarrhea and the treatment of enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains. It is a glycopeptide antibiotic whose oral formulation is used for these indications.

RELATED: C. diff Infection Tied to Higher Risk of Post-Op Mortality

Ani’s Vancomycin HCl Capsules are available in 125mg and 250mg strengths in packs of 2 cards containing 10 capsules each.

For more information call (800) 434-1121 or visit